Solution Nation Headquarters: Ness Ziona, Israel
Investor Relations: Irina Koffler / +1 917 734 7387 / ikoffler@lifesciadvisors.com
Description
Sol-Gel is a dermatology company focused on commercializing branded and generic topical drug products for the treatment of skin diseases. Sol-Gel leverages its proprietary microencapsulation technology platform for TWYNEO, which is FDA approved for the treatment of acne vulgaris in adults and pediatric patients nine years of age and older.
Industry
Life Sciences
Year Founded
Ownership
Public
Exchange / Symbol
NASDAQ: SLGL
Public Since
Chief Executive Officer
Chairman of the Board
Chief Financial Officer
Insider Ownership
Key Investors
Employee Count
Auditors
Investment Bankers
Law Firms
In the CEOs Own Words
Corporate Mission
Proudest Accomplishment
Next Milestone
Geographic Markets Served
Growth Drivers
Growth Headwinds
Indicia of Customer Satisfaction
Scalability
Workforce
Focus of Recruitment
Research and Development
Patent Count
Economic Sensitivity
Unique Metrics
Greatest Concern
Company Reports and Communications
SEC Filings
" target="_blank">